Literature DB >> 11576366

Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers.

J I Tokars1, T Gehr, W R Jarvis, J Anderson, N Armistead, E R Miller, J Parrish, S Qaiyumi, M Arduino, S C Holt, F C Tenover, G Westbrook, P Light.   

Abstract

BACKGROUND: Vancomycin-resistant enterococci (VRE) are increasing in prevalence at many institutions, and are often reported in dialysis patients. We studied the prevalence of and risk factors for VRE at seven outpatient hemodialysis centers (three in Baltimore, MD, USA, and four in Richmond, VA, USA).
METHODS: Rectal or stool cultures were performed on consenting hemodialysis patients during December 1997 to April 1998. Consenting patients were recultured during May to July 1998 (median 120 days later). Clinical and laboratory data and functional status (1 to 10 scale: 1, normal function; 9, home attendant, not totally disabled; 10, disabled, living at home) were recorded.
RESULTS: Of 478 cultures performed, 20 (4.2%) were positive for VRE. Among the seven centers, the prevalence of VRE-positive cultures varied from 1.0 to 7.9%. Independently significant risk factors for a VRE-positive culture were a functional score of 9 to 10 (odds ratio 6.9, P < 0.001), antimicrobial receipt within 90 days before culture (odds ratio 6.1, P < 0.001), and a history of injection drug use (odds ratio 5.4, P = 0.004).
CONCLUSIONS: VRE-colonized patients were present at all seven participating centers, suggesting that careful infection-control precautions should be used at all centers to limit transmission. In agreement with previous studies, VRE colonization was more frequent in patients who had received antimicrobial agents recently, underscoring the importance of judicious antimicrobial use in limiting selection for this potential pathogen.

Entities:  

Mesh:

Year:  2001        PMID: 11576366     DOI: 10.1046/j.1523-1755.2001.00955.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

2.  Contamination of renal patients' hospital chart covers with vancomycin-- resistant enterococci: Handle with care.

Authors:  Edward Zimbudzi; Rhonda L Stuart; Tony M Korman; Despina Kotsanas
Journal:  Australas Med J       Date:  2011-10-31

Review 3.  Infectious disease risks in pediatric renal transplantation.

Authors:  Felicia A Scaggs Huang; Lara Danziger-Isakov
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.651

4.  Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.

Authors:  Maria Cecília S Freitas; Alvaro Pacheco-Silva; Dulce Barbosa; Suzane Silbert; Hélio Sader; Ricardo Sesso; Luis Fernando A Camargo
Journal:  BMC Infect Dis       Date:  2006-08-22       Impact factor: 3.090

Review 5.  Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review.

Authors:  Anna Francis; Yeoungjee Cho; David W Johnson
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-17       Impact factor: 2.629

6.  Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: A systematic review.

Authors:  Saad Hanif Abbasi; Raja Ahsan Aftab; Siew Siang Chua
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

7.  Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006).

Authors:  S Shaghaghian; B Pourabbas; A Alborzi; M Askarian; J Mardaneh
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

8.  Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.

Authors:  Ojan Assadian; Mehrdad Askarian; Maria Stadler; Soheila Shaghaghian
Journal:  BMC Infect Dis       Date:  2007-06-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.